Global One-Step RT-PCR Kit Market Insights, Forecast to 2028
SKU ID : QYR-20166016 | Publishing Date : 08-Feb-2022 | No. of pages : 92
Market Analysis and Insights: Global One-Step RT-PCR Kit Market
Due to the COVID-19 pandemic, the global One-Step RT-PCR Kit market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, 30 Rxns accounting for % of the One-Step RT-PCR Kit global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Virus Detection segment is altered to an % CAGR throughout this forecast period.
China One-Step RT-PCR Kit market size is valued at US$ million in 2021, while the US and Europe One-Step RT-PCR Kit are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe One-Step RT-PCR Kit landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of One-Step RT-PCR Kit include Thermo Fisher Scientific, New England Biolabs, Boster Biological Technology Ltd, QIAGEN, Takara Bio (Takara Holdings) and Jena Bioscience, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global One-Step RT-PCR Kit Scope and Segment
One-Step RT-PCR Kit market is segmented by Type and by Application. Players, stakeholders, and other participants in the global One-Step RT-PCR Kit market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
30 Rxns
50 Rxns
100 Rxns
Other
Segment by Application
Virus Detection
Single-Cell RT-PCR
Gene-Expression Analysis
cDNA Synthesis
Other
By Company
Thermo Fisher Scientific
New England Biolabs
Boster Biological Technology Ltd
QIAGEN
Takara Bio (Takara Holdings)
Jena Bioscience
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Frequently Asked Questions
- By product type
- By End User/Applications
- By Technology
- By Region